Gill David N (CIK 0001106519)

Latest company ownership

Shares held
33,450
Last filed at
Sep 18, 2025
Confidence Score
48.6
2025Q4
Confidence Score History
2020Q4 2025Q4
OCGN - Ocugen, Inc.
Role: Director
Shares held
25,000
Last filed at
Jun 19, 2018
Confidence Score
50.0
2025Q4
Confidence Score History
2016Q4 2025Q4
EOLS - Evolus, Inc.
Role: Director
Shares held
11,146
Last filed at
Mar 11, 2025
Confidence Score
50.0
2025Q4
Confidence Score History
2018Q4 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Sep 16, 2025 Sep 18, 2025 Y-mAbs Therapeutics, Inc. Director Sell 42.5 -30,905 -100.00% ✗ $50.1K
May 13, 2024 May 15, 2024 Evolus, Inc. Director Sell 22.5 -10,361 -23.38% ✗ $131K
May 13, 2022 May 17, 2022 Evolus, Inc. Director Sell 22.5 -10,313 -25.86% ✗ $137.7K
Jan 19, 2021 Jan 20, 2021 Y-mAbs Therapeutics, Inc. Director Sell 10.0 -2,000 -100.00% ✓ $93K
Nov 18, 2020 Nov 20, 2020 Y-mAbs Therapeutics, Inc. Director Sell 10.0 -2,000 -100.00% ✓ $91.5K
Nov 3, 2020 Nov 5, 2020 Y-mAbs Therapeutics, Inc. Director Sell 10.0 -4,000 -100.00% ✓ $180K
Jun 13, 2019 Jun 14, 2019 Evolus, Inc. Director Buy 91.3 +2,000 66.67% ✗ $27.3K
Dec 14, 2018 Dec 17, 2018 Evolus, Inc. Director Buy 91.3 +3,000 100.00% ✗ $38.3K
Aug 16, 2017 Aug 17, 2017 Ocugen, Inc. Director Buy 90.0 +3,000 27.27% ✗ $5.4K
May 16, 2017 May 17, 2017 Ocugen, Inc. Director Buy 90.0 +3,000 37.50% ✗ $5K
Dec 15, 2016 Dec 15, 2016 Ocugen, Inc. Director Buy 90.0 +3,000 60.00% ✗ $5K
Dec 9, 2016 Dec 15, 2016 Ocugen, Inc. Director Buy 90.0 +5,000 100.00% ✗ $9.6K